Companies / Abbott Laboratories
Abbott Laboratories
Financials · FY2025
Ownership
1.73B shares outstanding · as of Jun 30, 2026
Ownership
| Insiders | 0.47% | 8,178,621 |
| Institutions | 83.93% | 1,452,246,673 |
| Public float | 15.60% | 269,958,002 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 18
View all →| Insider | % of shares | Shares |
|---|---|---|
Starks Daniel JDirector | 0.39% | 6,738,817 |
Ford Robert BCEOCHAIRMAN AND CEO · Director | 0.03% | 522,664 |
Salvadori Daniel Gesua SiveEVP AND GROUP PRESIDENT | <0.01% | 146,377 |
Conroy Kevin TDirector | <0.01% | 133,737 |
Moreland Mary KEXECUTIVE VICE PRESIDENT | <0.01% | 104,291 |
Earnhardt Lisa DEVP AND GROUP PRESIDENT | <0.01% | 90,407 |
Scoggins Christopher JEXECUTIVE VICE PRESIDENT | <0.01% | 77,126 |
Morrone Louis H.EXECUTIVE VICE PRESIDENT | <0.01% | 76,843 |
Boudreau Philip PEVP AND CFO | <0.01% | 71,172 |
Orville Jacob aSenior Vice President | <0.01% | 50,493 |
Institutional holders 3,280
View all →| Holder | Value | % of shares |
|---|---|---|
| $22.00B | 10.15% | |
| $13.84B | 8.82% | |
| $7.92B | 3.65% | |
| $7.34B | 4.68% | |
| $4.91B | 2.26% | |
| $4.60B | 2.12% | |
| $4.00B | 2.26% | |
| $2.94B | 1.36% | |
| $2.94B | 1.35% | |
| $2.78B | 1.28% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Ford Robert B CEO | Other | Common shares without par value | $3.52M | -30K -9.00% | 306,461 0.02% of shares | low |
| Jan 23, 2026 | Ford Robert B CEO | Buy | Common shares without par value | $2.01M | +19K +9.52% | 216,203 0.01% of shares | high |
| Feb 27, 2026 | Earnhardt Lisa D Executive | Other | Common shares without par value | $997.2K | -9K -8.67% | 90,407 <0.01% of shares | low |
| Feb 27, 2026 | Boudreau Philip P Executive | Other | Common shares without par value | $865.1K | -7K -9.47% | 71,172 <0.01% of shares | low |
| Feb 27, 2026 | Salvadori Daniel Gesua Sive Executive | Other | Common shares without par value | $769.1K | -7K -4.30% | 147,262 <0.01% of shares | low |
| Feb 27, 2026 | Scoggins Christopher J Executive | Other | Common shares without par value | $581.0K | -5K -6.08% | 77,126 <0.01% of shares | low |
| Feb 4, 2026 | Starks Daniel J Director | Buy | Common shares without par value | $545.2K | +5K +0.07% | 6,738,817 0.39% of shares | high |
| Feb 4, 2026 | Starks Daniel J Director | Buy | Common shares without par value | $542.1K | +5K +0.07% | 6,733,784 0.39% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ABT | — | 002824100 |